CHINA-COVID-19-PREVENTION AND CONTROL-PRODUCTION (CN)

CHINA-COVID-19-PREVENTION AND CONTROL-PRODUCTION (CN)

(220328) -- TIANJIN, March 28, 2022 (Xinhua) -- Staff members of a special steel enterprise check the health information of a man for entering the plant in north China's Tianjin, March 28, 2022. China has implemented differentiated epidemic control measures in factories to keep production stable in workshops of key enterprises and construction of major projects across the country. Over the past two-plus years, China's dynamic zero-COVID policy, featuring swift response, mass screening and large-scale vaccination, has not only prevented mass deaths at home but also ensured that factories can deliver products ranging from face masks to Teslas to consumers worldwide. (Xinhua/Sun Fanyue)

  • Product Code
  • ILEA000947422
  • Registered date
  • 2022/3/28 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 5568 × 3712 pixel
  • Resolution
  • dpi
  • Deployment size
  • 3.69(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    CHINA-TIANJIN-INTELLIGENT DRIVING-COMPETITION (CN)

    CHINA-TIANJIN-INTELLIGENT DRIVING-COMPETITION (CN)

    (240618) -- TIANJIN, June 18, 2024 Photo by Xinhua/ABACAPRESS.COM) -- A staff member installs a simulated pedestrian during the World Intelligent Driving Challenge 2024 in Dongli District of north China's Tianjin, June 18, 2024. This year's event set up challenges including information security attack and defense, real car intelligent network competition, mass production application challenge, etc., which attracted 109 teams from universities and enterprises across the country. Photo by Xinhua/ABACAPRESS.COM/Sun Fanyue)
      CHINA-MEDICINE PRODUCTION-COVID-19 (CN)

      CHINA-MEDICINE PRODUCTION-COVID-19 (CN)

      (221219) -- CHANGSHA, Dec. 19, 2022 (Xinhua) -- Staff members pack medicines at a pharmaceutical company in central China's Hunan Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. (Xinhua/Chen Sihan)
        CHINA-MEDICINE PRODUCTION-COVID-19 (CN)

        CHINA-MEDICINE PRODUCTION-COVID-19 (CN)

        (221219) -- XI'AN, Dec. 19, 2022 (Xinhua) -- Staff members work at a packaging workshop of a pharmaceutical company in Xi'an, northwest China's Shaanxi Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. (Photo by Zou Jingyi/Xinhua)
          CHINA-MEDICINE PRODUCTION-COVID-19 (CN)

          CHINA-MEDICINE PRODUCTION-COVID-19 (CN)

          (221219) -- CHANGSHA, Dec. 19, 2022 (Xinhua) -- Staff members pack medicines at a pharmaceutical company in central China's Hunan Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. (Xinhua/Chen Sihan)
            CHINA-MEDICINE PRODUCTION-COVID-19 (CN)

            CHINA-MEDICINE PRODUCTION-COVID-19 (CN)

            (221219) -- CHANGSHA, Dec. 19, 2022 (Xinhua) -- Staff members pack medicines at a pharmaceutical company in central China's Hunan Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. (Xinhua/Chen Sihan)
              CHINA-BEIJING-COVID-19 VACCINE-SECOND BOOSTER DOSE (CN)

              CHINA-BEIJING-COVID-19 VACCINE-SECOND BOOSTER DOSE (CN)

              (221217) -- BEIJING, Dec. 17, 2022 (Xinhua) -- A medical staff registers information for a resident at a temporary vaccination site in Haidian District, Beijing, capital of China, Dec. 17, 2022. China is continuing its optimization of COVID-19 epidemic prevention and control measures as it shifts the focus of its response strategy from curbing new infections to preventing and treating severe cases. On Wednesday, the government announced that it would offer a second booster dose of the COVID-19 vaccine to vulnerable groups who had received their first booster shot more than six months ago. (Xinhua/Ren Chao)
                CHINA-BEIJING-SUN CHUNLAN-INSPECTION (CN)

                CHINA-BEIJING-SUN CHUNLAN-INSPECTION (CN)

                (221214) -- BEIJING, Dec. 14, 2022 (Xinhua) -- Chinese Vice Premier Sun Chunlan inspects the Jianguomen community health service center in Beijing, capital of China, Dec. 13, 2022. Chinese Vice Premier Sun Chunlan on Tuesday stressed the importance of meticulously implementing various measures to optimize COVID-19 prevention and control, and ensuring the smooth transition of the country's COVID-19 response phases. Sun made the remarks during an inspection of epidemic control work in Beijing. (Xinhua/Yan Yan)

                  High-tech company in China's Shanghai resumes production amid COVID-19

                  STORY: High-tech company in China's Shanghai resumes production amid COVID-19 DATELINE: May 13, 2022 LENGTH: 00:01:08 LOCATION: SHANGHAI, China CATEGORY: HEALTH SHOTLIST: 1. SOUNDBITE (Chinese): SUN QING, Xinhua correspondent 2. SOUNDBITE (Chinese): XIONG JUNDI, Director of factory office, Toplite 3. SOUNDBITE (Chinese): PAN YONGSHENG, Director of customer service center, Toplite STORYLINE: With the number of new COVID-19 infections continuing to go down, east China's Shanghai is seeing more factories return to normal operations. SOUNDBITE (Chinese): SUN QING, Xinhua correspondent "Where we're now here is Toplite company, which is a high-tech company specialized in LED device package. The company, located in Qingpu District in Shanghai, has resumed production." At present, about 100 employees are back to work at the company under closed-loop management. Strict epidemic prevention and control measures, as well as emergency response plans are in place to ensure smooth operation of the company. SOUNDBITE
                    CHINA-COVID-19-PREVENTION AND CONTROL-PRODUCTION (CN)

                    CHINA-COVID-19-PREVENTION AND CONTROL-PRODUCTION (CN)

                    (220328) -- HARBIN, March 28, 2022 (Xinhua) -- A staff member works at a workshop of Harbin Boiler Company Limited in Harbin, northeast China's Heilongjiang Province, March 28, 2022. China has implemented differentiated epidemic control measures in factories to keep production stable in workshops of key enterprises and construction of major projects across the country. Over the past two-plus years, China's dynamic zero-COVID policy, featuring swift response, mass screening and large-scale vaccination, has not only prevented mass deaths at home but also ensured that factories can deliver products ranging from face masks to Teslas to consumers worldwide. (Xinhua/Xie Jianfei)
                      CHINA-COVID-19-PREVENTION AND CONTROL-PRODUCTION (CN)

                      CHINA-COVID-19-PREVENTION AND CONTROL-PRODUCTION (CN)

                      (220328) -- SHENYANG, March 28, 2022 (Xinhua) -- A worker welds at a workshop in Shenyang, capital of northeast China's Liaoning Province, March 24, 2022. China has implemented differentiated epidemic control measures in factories to keep production stable in workshops of key enterprises and construction of major projects across the country. Over the past two-plus years, China's dynamic zero-COVID policy, featuring swift response, mass screening and large-scale vaccination, has not only prevented mass deaths at home but also ensured that factories can deliver products ranging from face masks to Teslas to consumers worldwide. (Xinhua)